AIIMS Transfers Indigenous Breast Cancer AI to BPL Tech
AIIMS Transfers Indigenous Breast Cancer AI to BPL Tech
The All India Institute of Medical Sciences (AIIMS) in New Delhi has made a major breakthrough in diagnostic oncology. Specifically, the institute transferred its patented AI mammography technology to BPL Technologies for commercial validation and deployment. Breast cancer remains the most diagnosed malignancy among women across India. Consequently, this industry-academia partnership addresses a critical shortage of subspecialized breast radiologists in remote health facilities.
Advancing AI Mammography Technology Through Industry Collaboration
The formal technology transfer occurred on September 16 at AIIMS New Delhi. AIIMS Director Dr. Nikhil Tandon and BPL Technologies CFO Ajay Jindal finalized the landmark agreement. Furthermore, senior faculty members, including Associate Dean Prof. Govind Makharia and IPR Cell Head Prof. Velpandian, attended the ceremony. Dr. Tandon emphasized the urgency of translating laboratory discoveries into scalable clinical tools. Therefore, the collaboration gives BPL Technologies the mandate to refine the software for commercial hospital integration.
Moreover, the Ministry of Education funded this pioneering initiative to foster indigenous healthcare innovations. Radiologists and machine learning engineers at AIIMS worked collaboratively for over eighteen months. In addition, the team designed the algorithm specifically to handle complex diagnostic challenges unique to Indian patient populations.
Clinical Performance and Diagnostic Architecture
Dr. Krithika Rangarajan from the Department of Radiology spearheaded the clinical development. Radiologists Dr. Amit Gupta and Dr. Varun Holla provided vital imaging expertise alongside data science specialists. Notably, the team trained the artificial intelligence model entirely on domestic mammography datasets. This design choice ensures optimal accuracy for Indian women, who frequently present with dense breast tissue at younger ages.
During retrospective validation on thousands of hospital scans, the model achieved a 99% negative predictive value. Hence, it functions exceptionally well as an autonomous second reader in radiology workflows. For instance, the system immediately flags suspicious microcalcifications and architectural distortions for human review. As a result, the tool acts as an essential safety net that prevents missed cancer diagnoses.
Bridging Healthcare Disparities Across India
Secondary and tertiary healthcare centers in non-metro cities often face severe shortages of expert onco-radiologists. Consequently, general radiologists and medical officers encounter high interpretation workloads that increase error rates. BPL Technologies plans to integrate this deep learning system into digital mammography suites and telemedicine networks. Thus, community clinics can soon deliver standardized, high-tier diagnostic evaluations without referring patients to distant medical colleges.
Ultimately, this technological milestone accelerates earlier cancer detection when curative interventions remain most effective. Clinicians anticipate nationwide deployment following final regulatory approvals, bringing sophisticated screening tools to underserved populations, which can be further explored through specialized breast radiology training.
Frequently Asked Questions
Q1: What role does the new AI mammography tool serve in clinical practice?
The algorithm serves as a concurrent second reader for mammograms. It alerts radiologists to occult malignant lesions and calcifications, significantly lowering missed diagnosis rates, a key focus area in modern clinical oncology education.
Q2: Why is training an AI model on Indian demographic data important?
Indian women frequently present with higher breast parenchymal density and develop breast cancer at a younger median age. Therefore, training algorithms on native cohorts ensures superior diagnostic accuracy compared to foreign models.
Q3: When will healthcare centers in India access this technology?
Following the technology transfer, BPL Technologies is pursuing clinical validation, product integration, and statutory regulatory approvals. Commercial rollout across partner hospitals is expected within the coming year.
References
- AIIMS transfers AI-based mammography technology to BPL Technologies - ETHealthworld
- AIIMS develops AI tool to help detect breast cancer on mammograms - The Times of India
- AIIMS Delhi transfers AI-based mammography interpretation technology to BPL Technologies Limited - ANI News
